Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer

Cynthia X. Ma, Ron Bose, Feng Gao, Rachel A. Freedman, Melinda L. Telli, Gretchen Kimmick, Eric Winer, Michael Naughton, Matthew P. Goetz, Christy Russell, Debu Tripathy, Melody Cobleigh, Andres Forero, Timothy J. Pluard, Carey Anders, Polly Ann Niravath, Shana Thomas, Jill Anderson, Caroline Bumb, Kimberly C. Banks, Richard B. Lanman, Richard Bryce, Alshad S. Lalani, John Pfeifer, Daniel F. Hayes, Mark Pegram, Kimberly Blackwell, Philippe L. Bedard, Hussam Al-Kateb, Matthew J.C. Ellis

Open source

DOI
10.1158/1078-0432.ccr-17-0900
Published
2017-10-01
Container
Clinical Cancer Research
Publisher
American Association for Cancer Research (AACR)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-17-0900,
  title = {Neratinib Efficacy and Circulating Tumor DNA Detection of
                    <i>HER2</i>
                    Mutations in
                    <i>HER2</i>
                    Nonamplified Metastatic Breast Cancer},
  author = {Cynthia X. Ma and Ron Bose and Feng Gao and Rachel A. Freedman and Melinda L. Telli and Gretchen Kimmick and Eric Winer and Michael Naughton and Matthew P. Goetz and Christy Russell and Debu Tripathy and Melody Cobleigh and Andres Forero and Timothy J. Pluard and Carey Anders and Polly Ann Niravath and Shana Thomas and Jill Anderson and Caroline Bumb and Kimberly C. Banks and Richard B. Lanman and Richard Bryce and Alshad S. Lalani and John Pfeifer and Daniel F. Hayes and Mark Pegram and Kimberly Blackwell and Philippe L. Bedard and Hussam Al-Kateb and Matthew J.C. Ellis},
  year = {2017},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-17-0900},
  url = {https://doi.org/10.1158/1078-0432.ccr-17-0900}
}

RIS

TY  - JOUR
TI  - Neratinib Efficacy and Circulating Tumor DNA Detection of
                    <i>HER2</i>
                    Mutations in
                    <i>HER2</i>
                    Nonamplified Metastatic Breast Cancer
AU  - Cynthia X. Ma
AU  - Ron Bose
AU  - Feng Gao
AU  - Rachel A. Freedman
AU  - Melinda L. Telli
AU  - Gretchen Kimmick
AU  - Eric Winer
AU  - Michael Naughton
AU  - Matthew P. Goetz
AU  - Christy Russell
AU  - Debu Tripathy
AU  - Melody Cobleigh
AU  - Andres Forero
AU  - Timothy J. Pluard
AU  - Carey Anders
AU  - Polly Ann Niravath
AU  - Shana Thomas
AU  - Jill Anderson
AU  - Caroline Bumb
AU  - Kimberly C. Banks
AU  - Richard B. Lanman
AU  - Richard Bryce
AU  - Alshad S. Lalani
AU  - John Pfeifer
AU  - Daniel F. Hayes
AU  - Mark Pegram
AU  - Kimberly Blackwell
AU  - Philippe L. Bedard
AU  - Hussam Al-Kateb
AU  - Matthew J.C. Ellis
PY  - 2017
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-17-0900
UR  - https://doi.org/10.1158/1078-0432.ccr-17-0900
ER  -

APA

Ma, C. X., Bose, R., Gao, F., Freedman, R. A., Telli, M. L., Kimmick, G., Winer, E., Naughton, M., Goetz, M. P., Russell, C., Tripathy, D., Cobleigh, M., Forero, A., Pluard, T. J., Anders, C., Niravath, P. A., Thomas, S., Anderson, J., Bumb, C., Banks, K. C., Lanman, R. B., Bryce, R., Lalani, A. S., Pfeifer, J., Hayes, D. F., Pegram, M., Blackwell, K., Bedard, P. L., Al-Kateb, H., & Ellis, M. J. (2017). Neratinib Efficacy and Circulating Tumor DNA Detection of <i>HER2</i> Mutations in <i>HER2</i> Nonamplified Metastatic Breast Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-17-0900

Source records